133 related articles for article (PubMed ID: 33804251)
41. The utility of PET/CT with (68)Ga-DOTATOC in sarcoidosis: comparison with (67)Ga-scintigraphy.
Nobashi T; Nakamoto Y; Kubo T; Ishimori T; Handa T; Tanizawa K; Sano K; Mishima M; Togashi K
Ann Nucl Med; 2016 Oct; 30(8):544-52. PubMed ID: 27272495
[TBL] [Abstract][Full Text] [Related]
42. Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
Albers MB; Librizzi D; Lopez CL; Manoharan J; Apitzsch JC; Slater EP; Bollmann C; Kann PH; Bartsch DK
World J Surg; 2017 Jun; 41(6):1521-1527. PubMed ID: 28138732
[TBL] [Abstract][Full Text] [Related]
43. Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
Van Binnebeek S; Vanbilloen B; Baete K; Terwinghe C; Koole M; Mottaghy FM; Clement PM; Mortelmans L; Bogaerts K; Haustermans K; Nackaerts K; Van Cutsem E; Verslype C; Verbruggen A; Deroose CM
Eur Radiol; 2016 Mar; 26(3):900-9. PubMed ID: 26162577
[TBL] [Abstract][Full Text] [Related]
44. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Diagnostic Sensitivity and Quantitative Indices Between (68)Ga-DOTATOC PET/CT and (111)In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report.
Lee I; Paeng JC; Lee SJ; Shin CS; Jang JY; Cheon GJ; Lee DS; Chung JK; Kang KW
Nucl Med Mol Imaging; 2015 Dec; 49(4):284-90. PubMed ID: 26550047
[TBL] [Abstract][Full Text] [Related]
46. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
[TBL] [Abstract][Full Text] [Related]
47. Clinical utility of
Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
Koukouraki S; Strauss LG; Georgoulias V; Schuhmacher J; Haberkorn U; Karkavitsas N; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):460-6. PubMed ID: 16437218
[TBL] [Abstract][Full Text] [Related]
49. 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Provost C; Prignon A; Cazes A; Combaret V; Delattre O; Janoueix-Lerosey I; Montravers F; Talbot JN
Anticancer Res; 2016 Sep; 36(9):4459-66. PubMed ID: 27630282
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
Kowalski J; Henze M; Schuhmacher J; Mäcke HR; Hofmann M; Haberkorn U
Mol Imaging Biol; 2003; 5(1):42-8. PubMed ID: 14499161
[TBL] [Abstract][Full Text] [Related]
51. Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
Sheehan JP; Starke RM; Kano H; Kaufmann AM; Mathieu D; Zeiler FA; West M; Chao ST; Varma G; Chiang VL; Yu JB; McBride HL; Nakaji P; Youssef E; Honea N; Rush S; Kondziolka D; Lee JY; Bailey RL; Kunwar S; Petti P; Lunsford LD
J Neurosurg; 2014 Jun; 120(6):1268-77. PubMed ID: 24678777
[TBL] [Abstract][Full Text] [Related]
52. Quantitative tumor volumetric responses after Gamma Knife radiosurgery for meningiomas.
Harrison G; Kano H; Lunsford LD; Flickinger JC; Kondziolka D
J Neurosurg; 2016 Jan; 124(1):146-54. PubMed ID: 26162039
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
54. Localization of Unknown Primary Site with
Menda Y; O'Dorisio TM; Howe JR; Schultz M; Dillon JS; Dick D; Watkins GL; Ginader T; Bushnell DL; Sunderland JJ; Zamba GKD; Graham M; O'Dorisio MS
J Nucl Med; 2017 Jul; 58(7):1054-1057. PubMed ID: 28153957
[TBL] [Abstract][Full Text] [Related]
55. Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia.
Froeling V; Elgeti F; Maurer MH; Scheurig-Muenkler C; Beck A; Kroencke TJ; Pape UF; Hamm B; Brenner W; Schreiter NF
Ann Nucl Med; 2012 Nov; 26(9):738-43. PubMed ID: 22865406
[TBL] [Abstract][Full Text] [Related]
56. Parametric Net Influx Rate Images of
Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M
J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716
[No Abstract] [Full Text] [Related]
57. Hearing preservation after Gamma Knife radiosurgery for cerebellopontine angle meningiomas.
El-Shehaby AMN; Reda WA; Abdel Karim KM; Nabeel AM; Emad Eldin RM; Tawadros SR
J Neurosurg; 2018 Dec; 129(Suppl1):38-46. PubMed ID: 30544298
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous
Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
[TBL] [Abstract][Full Text] [Related]
59. Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.
Kratochwil C; Giesel FL; López-Benítez R; Schimpfky N; Kunze K; Eisenhut M; Kauczor HU; Haberkorn U
Clin Cancer Res; 2010 May; 16(10):2899-905. PubMed ID: 20460485
[TBL] [Abstract][Full Text] [Related]
60. Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumor.
Todorović-Tirnanić M; Kaemmerer D; Prasad V; Hommann M; Baum RP
Recent Results Cancer Res; 2013; 194():487-96. PubMed ID: 22918778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]